CHARACTERIZATION OF THE MECHANISMS ASSOCIATED TO THERAPEUTIC EFFECTS OBSERVED SFTER MESENCHYMAL STEM CELL ADMINISTRATION INTO MICE WITH THE HEPATIC MANIFESTATION OF METABOLIC SYNDROME.

dc.date.accessioned2017-07-03T22:10:44Z
dc.date.available2017-07-03T22:10:44Z
dc.date.created2017-07-03T22:10:44Z
dc.date.issued2008
dc.identifierhttp://hdl.handle.net/10533/201317
dc.identifier11085034
dc.languagespa
dc.relationhandle/10533/168881
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/11085034
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/111615
dc.relationhandle/10533/168878
dc.relationhandle/10533/108045
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.titleCHARACTERIZATION OF THE MECHANISMS ASSOCIATED TO THERAPEUTIC EFFECTS OBSERVED SFTER MESENCHYMAL STEM CELL ADMINISTRATION INTO MICE WITH THE HEPATIC MANIFESTATION OF METABOLIC SYNDROME.
dc.typeInforme Final


Este ítem pertenece a la siguiente institución